Clinical outcome and predictive factors for docetaxel and epirubicin neoadjuvant chemotherapy of locally advanced breast cancer

BACKGROUND/AIMS: We evaluated the efficacy of docetaxel and epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer and assessed the predictive factors for response to neoadjuvant chemotherapy and prognostic factors related to relapse-free survival. METHODS: Forty patients who recei...

Descripción completa

Detalles Bibliográficos
Autores principales: Won, Hye Sung, Kim, Yong Seok, Kim, Jeong Soo, Chang, Eun Deok, Na, Sae Jung, Whang, In Yong, Lee, Dong Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652641/
https://www.ncbi.nlm.nih.gov/pubmed/32069523
http://dx.doi.org/10.3904/kjim.2019.031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652641/
https://www.ncbi.nlm.nih.gov/pubmed/32069523
http://dx.doi.org/10.3904/kjim.2019.031

Ejemplares similares